triptolide has been researched along with Osteoporosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Huang, Z; Lian, K; Lin, D; Luo, D; Ren, H; Xian, H; Zhang, H; Zhang, P | 1 |
Wang, B; Wang, Y; Yang, X | 1 |
Park, B | 1 |
1 review(s) available for triptolide and Osteoporosis
Article | Year |
---|---|
The Study of Cellular Mechanism of Triptolide in the Treatment of Cancer, Bone Loss and Cardiovascular Disease and Triptolide's Toxicity.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Arthritis, Rheumatoid; Autophagy; Cardiovascular Diseases; Diterpenes; Epoxy Compounds; Humans; Medicine, Chinese Traditional; Neoplasms; Osteoporosis; Phenanthrenes; Plant Extracts; Signal Transduction; Tripterygium | 2020 |
2 other study(ies) available for triptolide and Osteoporosis
Article | Year |
---|---|
The protective effects of triptolide on age-related bone loss in old male rats.
Topics: Animals; Bone Resorption; Diterpenes; Epoxy Compounds; Male; Osteoclasts; Osteoporosis; Phenanthrenes; Rats; Rats, Sprague-Dawley | 2018 |
Triptolide, a diterpene, inhibits osteoclastogenesis, induced by RANKL signaling and human cancer cells.
Topics: Animals; Bone Resorption; Cell Differentiation; Cell Line, Tumor; Diterpenes; Epoxy Compounds; Humans; Mice; Neoplasms; Osteoclasts; Osteoporosis; Phenanthrenes; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Signal Transduction | 2014 |